Etanercept
0881A6-4625
Approved small_molecule completed
Quick answer
Etanercept for Moderate to Severe Psoriasis is a Approved program (small_molecule) at Pfizer with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer
- Indication
- Moderate to Severe Psoriasis
- Phase
- Approved
- Modality
- small_molecule
- Status
- completed